US2007116654A1PendingUtilityA1

Cosmetics

Assignee: SHISEIDO CO LTDPriority: Jan 19, 2001Filed: Dec 13, 2006Published: May 24, 2007
Est. expiryJan 19, 2021(expired)· nominal 20-yr term from priority
A61P 3/02A61P 17/00A61Q 1/06A61K 8/86A61K 8/37A61Q 19/08A61Q 1/02A61K 8/345A61Q 5/00A61K 47/14A61K 47/10A61K 2800/75A61K 31/07A61Q 17/04A61Q 19/00A61K 9/0014A61K 8/72A61Q 17/00
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The cosmetic of the present invention is a cosmetic that alleviates skin irritation by blending in polypropylene glycol, a specific polar oil, or polybutylene glycol, as well as an ultraviolet absorbent. The present invention also relates to an agent and a method for alleviating irritation by lipophilic drugs. Since the present invention alleviates skin irritation due to ultraviolet absorbents and lipophilic drugs in cosmetics, any amount of ultraviolet absorbents and lipophilic drugs can be blended in cosmetics, and therefore cosmetics that can fully manifest their effects can be provided. Also, it is possible to prepare a safe sunblock cosmetic with superior ultraviolet protection effects because the ultraviolet absorbent is not absorbed through skin.

Claims

exact text as granted — not AI-modified
1 - 4 . (canceled)  
   
   
       5 . A skin absorption suppression agent for an ultraviolet absorbent comprising polypropylene glycol.  
   
   
       6 . A skin absorption suppression agent for an ultraviolet absorbent comprising at least one of the following polar oils; 
 diethoxyethyl succinate, diethyl sebacate, diisopropyl sebacate, isononyl isononanoate, dioctyl succinate, trioctanoin, pentaerythrityl tetraoctanoate, and cetyl octanoate.    
   
   
       7 - 10 . (canceled)  
   
   
       11 . An irritation alleviating agent for lipophilic drugs comprising polypropylene glycol.  
   
   
       12 . An irritation alleviating agent for lipophilic drugs comprising polar oil.  
   
   
       13 . A method of alleviating irritation by lipophilic drugs using the irritation alleviating agent of  claim 11 .  
   
   
       14 . An irritation alleviating endermic liniment containing the irritation alleviating agent  claim 11 .  
   
   
       15 . An endermic liniment comprising retinol and polypropylene glycol having a number average molecular weight of 1,500-2,500.  
   
   
       16 . An irritation alleviating agent for lipophilic drugs comprising polybutylene glycol.  
   
   
       17 . A method of alleviating irritation by lipophilic drugs using the irritation alleviating agent of  claim 16 .  
   
   
       18 . An irritation alleviating endermic liniment containing the irritation alleviating agent of  claim 16 .  
   
   
       19 . A method of alleviating irritation by lipophilic drugs using the irritation alleviating agent of  claim 12 .  
   
   
       20 . An irritation alleviating endermic liniment containing the irritation alleviating agent  claim 12.

Join the waitlist — get patent alerts

Track US2007116654A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.